Related Experiment Video
Updated: Mar 1, 2026

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
Corrigendum: Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.
Alejandro Romero1, Eva Ramos1, Paloma Patiño2
1Department of Toxicology and Pharmacology, Faculty of Veterinary Medicine, Complutense University of MadridMadrid, Spain.
This correction notice pertains to a previously published article. It addresses an error on page 281 of volume 8, referencing PMID: 27932976.
Area of Science:
- Scientific publishing
- Article corrections
- Bibliographic accuracy
Context:
- Correction of a specific article
- Volume 8, page 281
- PMID: 27932976
Purpose:
- To rectify an error in the scientific record
- Ensure accurate citation and referencing
- Maintain the integrity of published research
Summary:
- A correction has been issued for an article.
- The error is located on page 281 of volume 8.
- The article is identified by PMID: 27932976.
Impact:
- Ensures readers access the correct information.
- Prevents the propagation of misinformation.
- Upholds scholarly communication standards.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Management of Insomnia
Antidepressant Drugs: MAOIs and Other Agents
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Drugs Affecting Neurotransmitter Synthesis

